Impact of Novel Targeted Therapies and Cytogenetic Risk Groups on Outcome After Allogeneic Transplantation for Adult ALL

Zaid H. Abdel Rahman, Michael G. Heckman, Kevin Miller, Hassan Alkhateeb, Mrinal S. Patnaik, Lisa Z. Sproat, Liuyan Jiang, Vivek Roy, Hemant S. Murthy, Ernesto Ayala, William J. Hogan, Patricia T. Greipp, Mohamed A. Kharfan-Dabaja, Mark R. Litzow, James M. Foran

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Impact of Novel Targeted Therapies and Cytogenetic Risk Groups on Outcome After Allogeneic Transplantation for Adult ALL'. Together they form a unique fingerprint.

Medicine & Life Sciences